Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2005
10/05/2005CN1221546C Diphenyl azetidinone derivatives, method for prodn. thereof, medicaments contg. these compounds, and their use
10/05/2005CN1221544C Pyrazole cyclic AMP-specific PDE inhibitors
10/05/2005CN1221542C Methods for separating tocol from tocol-containing mixture
10/05/2005CN1221540C Chiral sugarapple lactone compound modified by ether bond, its synthesis method and application
10/05/2005CN1221536C New derivatives of cyano-aryl (or cyanoheteroaryl)-carbonyl-piperazinyl- pyrimidines, their preparation and application as medication
10/05/2005CN1221535C Spiroimidazolidine derivatives, their prepn. their use and pharmaceutical preparation comprising them
10/05/2005CN1221534C Substited 8-arylquinoline phosphodiesterase-4 inhibitors
10/05/2005CN1221533C 7-amino-1H-indole derivatives
10/05/2005CN1221529C Substituted N-[(aminoiminomethyl or aminomethyl) phenyl] propyl amides
10/05/2005CN1221527C Novel crystal of stilbene derivative and process for producing the same
10/05/2005CN1221524C Diphenyl ether compounds useful in therapy
10/05/2005CN1221523C Novel di-quaternary ammonium salt compound
10/05/2005CN1221281C Oral, nasal and pulmonary dosage formulations of copolymer1
10/05/2005CN1221278C 'Naoan' preparation for curing apoplexy and migraine and producing method
10/05/2005CN1221271C Chinese medicinal external preparation for treating ulcer of lower limbs
10/05/2005CN1221270C Method for preparation of eye drop of bark of ash
10/05/2005CN1221267C Feeze-dried powder injection contg. total saponin by refinement of American ginseng and leaves and stem of Americal ginseng, and its prodction process
10/05/2005CN1221266C Compound preparation containing alpha-linolic acid, lecithin and ginkgo flavone
10/05/2005CN1221265C Triazineon compounds for treating diseases due to sarcosystis, neospora and toxoplasma
10/05/2005CN1221264C Medicine composition of local administration for treating herpes zoster
10/05/2005CN1221263C Gel type medicinal composition for treating acne and preparation process thereof
10/05/2005CN1221262C Phthalazine derivatives for treating inflammatory diseases
10/05/2005CN1221261C Flunarizine hydrochloride high-capacity injecta and preparing process thereof
10/05/2005CN1221260C Use of oxidized matrine in preparation of medicine for treating venereal diseases
10/05/2005CN1221259C Preparation method of medicine for curing urteriosclerosis by using CS-866, losartan and candisartan
10/05/2005CN1221258C Application of bendazac lysine in the preparing process of medicine for preventing and treating diabetic nephropathy
10/05/2005CN1221257C Utilization of aryl (or heteroaryl) azolylcarbinol derivatives in prepn. of medicament for treatment of neurogenic inflammation
10/05/2005CN1221256C 药物组合物 The pharmaceutical composition of
10/05/2005CN1221255C New use of sulpiride in pharmacy
10/05/2005CN1221254C New combination of serotonin agonist (5HT2) and antagonist (5HT6) as pharmaceutical formulation
10/05/2005CN1221253C Application of tea polyphenol in medicine to treat diseases in respiratory system
10/05/2005CN1221252C Process for preparing slow-releasing indapamide tablet
10/05/2005CN1221249C Injectable aqueous dispersions of propofol
10/05/2005CN1221248C Preparation method for antibiotics composition
10/05/2005CN1221246C Use of medicine having chemical compound for promoting collagen synthesizing activity
10/05/2005CN1221244C Micropigment mixture
10/05/2005CN1221243C Antiperspirant products
10/05/2005CN1221238C Use of oximino-and hydroxylamino-prostaglandins
10/05/2005CN1221237C Composition for treatment of scars skin disease
10/05/2005CN1221190C Composition and method for smoke detoxification
10/05/2005CN1221182C Synanthrin products with improved nutritional properties
10/04/2005USRE38813 chemically stable skin care compositions comprising a water-in-oil emulsion and certain retinoids; retinol (Vitamin A alcohol), retinal (Vitamin A aldehyde), retinyl acetate, retinyl palmitate and mixtures thereof
10/04/2005US6952650 Modulators of ribosomal function and identification thereof
10/04/2005US6951961 Methods of use and compositions for the diagnosis and treatment of infectious disease
10/04/2005US6951953 comprises high tumor tissue selectivity due to enhanced permeability and retention effect
10/04/2005US6951950 such as (3S)-3-(2-amino-2-oxo-1,1-diphenylethyl)-1-[2-(2,3-dihydro-1-benzofuran-5-yl)ethyl]-1-methylpyrrolidinium iodide for treatment of asthma, chronic obstructive pulmonary disorder, allergic rhinitis, and infectious rhinitis
10/04/2005US6951942 Glucocorticoid-selective anti-inflammatory agents
10/04/2005US6951940 Analgesics, antiinflammatory agents, antiallergens, autoimmune disease, cardiovascular disorders
10/04/2005US6951939 Multivalent platform molecules comprising high molecular weight polyethylene oxide
10/04/2005US6951938 Aryl fused azapolycyclic compounds
10/04/2005US6951937 Nitrogenous heterocyclic compounds and process for making nitrogenous heterocyclic compounds and intermediates thereof
10/04/2005US6951934 Method for preparing functionalized β-(1,3)-glucan derivatives
10/04/2005US6951923 For regenerating tissues; antiaging agents; medical diagnosis; monitoring chemotherapy
10/04/2005US6951890 Preventing and/or treating cardiovascular disease and/or associated heart failure
10/04/2005US6951889 7-acetamidinyl derivatives
10/04/2005US6951888 Betamimetics with a prolonged duration of activity, processes for preparing them, and their use as pharmaceutical compositions
10/04/2005US6951887 Lipoic acid derivatives and their use in treatment of disease
10/04/2005US6951885 Pharmaceutical composition
10/04/2005US6951884 Fluorobenzamides and uses thereof
10/04/2005US6951883 2H-1-benzopyran derivatives processes for their preparation and pharmaceutical compositions thereof
10/04/2005US6951882 treating obesity or a sleep/wake disorder mediated by orexin-2; antagonists
10/04/2005US6951879 Heteroaromate OSC inhibitors
10/04/2005US6951877 Materials and methods for treating hypercholesterolemia
10/04/2005US6951876 Sulfamoylheteroaryl pyrazole compounds as anti-inflammatory/analgesic agents
10/04/2005US6951875 Conjugated aromatic compounds with a pyridine substituent
10/04/2005US6951874 Compounds
10/04/2005US6951873 Cognitive dysfunction syndrome in cats and dogs; substituted piperidines, fused heterocycles
10/04/2005US6951872 Monocyclic or bicyclic carbocycles and heterocycles as factor Xa inhibitors
10/04/2005US6951871 Indole derivatives useful as histamine H3 antagonists
10/04/2005US6951870 Ortho-diihydroxy- coumarin or 1,2--dihydroquinoline derivatives as catechol-O-methyltransferase enzyme inhibitors for Parkinson*s disease treatment
10/04/2005US6951869 Treating capsular contracture during breast implant surgery
10/04/2005US6951868 Central nervous system disorders, gastrointestinal disorders;side effect reduction
10/04/2005US6951863 Pyridoarylphenly oxazolidinone antibacterials, and related compositions and methods
10/04/2005US6951862 Calcium channel blockers comprising two benzhydril moieties
10/04/2005US6951861 Chemical compounds
10/04/2005US6951859 Anticancer agents; diseases associated with signal trans-duction pathways operating through growth factor receptors
10/04/2005US6951858 Substituted 1,2,4-triazine-3,5-diones; male and female sex hormone related conditions
10/04/2005US6951857 Interleukins; cytokines; for treating eosinophil-dependent inflammatory disease/bronchial asthma
10/04/2005US6951856 Substituted pyrimidine-sulfonamide derivatives are used as endothelin receptor antagonists
10/04/2005US6951855 vascular damaging agents
10/04/2005US6951854 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
10/04/2005US6951853 DNA sequence selective agents as potential antitumor compounds
10/04/2005US6951852 osteoarthritis; little to no intrinsic estrogenicity; antagonizes the effects of 17 beta -estradiol with minimal uterine stimulation; bone loss inhibitor
10/04/2005US6951851 Substituted pyrazoles
10/04/2005US6951850 Dipeptide derivatives
10/04/2005US6951849 Psychological disorders; central nervous system disorders; schizophrenia
10/04/2005US6951847 Methods of treating fungal infections using lupeol
10/04/2005US6951846 Comprises artesunic acid complexed with cyclodextrins, which shields peroxide portion of artemisinin backbone from hydrolytic decomposition; for treatment of malaria
10/04/2005US6951844 substituted 5-phenyl-2-naphthols; metabolic disorders
10/04/2005US6951841 Bioavailability; side effect reduction
10/04/2005US6951657 Particles coated with granulated crystalline ibuprofen
10/04/2005US6951656 Microprecipitation method for preparing submicron suspensions
10/04/2005US6951654 Intravaginal drug delivery devices for the administration of an antimicrobial agent
10/04/2005US6951641 administering a dimeric nonionic X-ray contrast media selected from iotrolan and iodixannol to an eye of a mammal suffering allergic conjunctivtis and allergic rhinitis
10/04/2005US6951640 Imaging tumors using organometallic porphyrin
10/04/2005US6951219 Treatment of hepatitis C using hyperthermia
10/04/2005CA2301706C Use of phanquinone for the treatment of alzheimer's disease
10/04/2005CA2262862C Angiogenic inhibitory compounds
10/04/2005CA2245539C Condensed 2,3-benzodiazepine derivatives and their use as ampa-receptor inhibitors
10/04/2005CA2243706C Azolyl piperazinyl phenyl oxazolidinone antimicrobials
1 ... 4520 4521 4522 4523 4524 4525 4526 4527 4528 4529 4530 4531 4532 4533 4534 4535 4536 4537 4538 4539 4540 ... 7860